US FDA ‘Project Post COVIDity’ Will Track Infection Impact On Cancer Patients Using Real-World Data
• By Grace Moser
Tracking the impact of COVID infections on cancer patients using real-world data is among the new projects launched by the US FDA’s Oncology Center of Excellence. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".